MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) plans to report its second-quarter 2026 financial and operating results before U.S. markets open on Aug. 11, with management scheduled to discuss the results during a conference call later that morning.
The medical technology company said it will release earnings before the opening bell on Tuesday, Aug. 11, and host a conference call at 8:30 a.m. Eastern Time.
The earnings call will be available through a live webcast in listen-only mode at https://edge.media-server.com/mmc/p/7ri4xna9. Participants who wish to listen by telephone may register in advance at https://register-conf.media-server.com/register/BI08c32afb52ea4f2aa3ab6c2a86592eca.
Neuronetics develops and markets the NeuroStar transcranial magnetic stimulation (TMS) system and, through its Greenbrook network, operates one of the nation’s largest interventional psychiatry clinic networks offering TMS and SPRAVATO therapy.
The NeuroStar Advanced Therapy System has received U.S. Food and Drug Administration clearances for use in adults with major depressive disorder, as an adjunctive treatment for obsessive-compulsive disorder, to reduce anxiety symptoms in adults with major depressive disorder who also experience anxiety symptoms, and as a first-line adjunctive treatment for major depressive disorder in patients ages 15 to 21.
The company said the Aug. 11 conference call will review its financial and operating performance for the quarter ended June 30, 2026.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.